Kukla A, Radosevich D M, Finger E B, Kandaswamy R
Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, Minnesota.
Department of Surgery, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
Transplant Proc. 2014 Jul-Aug;46(6):1938-41. doi: 10.1016/j.transproceed.2014.05.081.
Compared with enteric drainage, bladder-drained solitary pancreas transplants can be monitored for rejection by measuring urine amylase levels. However, bladder drainage is associated with a higher risk of infection and metabolic complications, necessitating enteric conversion in about one third of patients. We hypothesized that hypersecreting pancreata with high urine amylase levels have a higher propensity for enteric conversion from an antecedent elevated enzymatic effect on the urinary tract and increased fluid losses.
We analyzed the risk for enteric conversion in 312 bladder-drained solitary pancreas transplant recipients. Urine amylase levels at 30 days were used to identify those at risk for enteric conversion. Time-to-event analysis was used to evaluate the risk of enteric conversion at 10 years, adjusting for urine amylase level and other confounding factors. Confounding risk factors statistically related to enteric conversion were incorporated into the multivariable analysis by using Cox proportional hazards regression at 3 years' posttransplant.
During the median follow-up of 184.6 months, 31% of recipients underwent duct conversion. A majority of recipients (84.5%) who required duct conversion were primary transplants. The 30-day median urine amylase level was 1749 IU/h (quartile 1, <777 IU/h; quartile 3, ≥3272 IU/h). Using receiver operating characteristic analysis, it was determined that urine amylase levels >3272 IU/h had the greatest specificity for predicting risk of enteric conversion. In the multivariate analysis, high urine amylase levels increased the risk of enteric conversion only in repeated pancreas transplants.
Primary transplants are more likely to undergo enteric conversion than retransplants. High urine amylase levels increase the risk of enteric conversion in retransplants only, and therefore this enzyme alone cannot serve as the sole predictor for conversion in primary transplants. Other factors, such as fluid and bicarbonate losses, increased bladder pressure, and a pre-existing lower urinary tract pathologic condition may be also responsible for the development of complications; these factors warrant additional study.
与肠道引流相比,膀胱引流的孤立胰腺移植可通过测量尿淀粉酶水平来监测排斥反应。然而,膀胱引流与更高的感染和代谢并发症风险相关,约三分之一的患者需要进行肠道改道。我们推测,尿淀粉酶水平高的高分泌胰腺因对尿路的酶促作用升高和液体流失增加,肠道改道的倾向更高。
我们分析了312例膀胱引流的孤立胰腺移植受者肠道改道的风险。用30天时的尿淀粉酶水平来确定有肠道改道风险的患者。采用事件发生时间分析来评估10年时肠道改道的风险,并对尿淀粉酶水平和其他混杂因素进行校正。在移植后3年,通过Cox比例风险回归将与肠道改道有统计学关联的混杂风险因素纳入多变量分析。
在184.6个月的中位随访期内,31%的受者进行了导管改道。大多数需要导管改道的受者(84.5%)是初次移植。30天的尿淀粉酶水平中位数为1749 IU/h(四分位数1,<777 IU/h;四分位数3,≥3272 IU/h)。通过受试者操作特征分析确定,尿淀粉酶水平>3272 IU/h对预测肠道改道风险具有最大特异性。在多变量分析中,高尿淀粉酶水平仅在再次胰腺移植中增加肠道改道风险。
初次移植比再次移植更有可能进行肠道改道。高尿淀粉酶水平仅在再次移植中增加肠道改道风险,因此该酶不能单独作为初次移植改道的唯一预测指标。其他因素,如液体和碳酸氢盐流失、膀胱压力增加以及既往存在的下尿路病理状况,也可能导致并发症的发生;这些因素值得进一步研究。